Session 3: Targeted therapy
๐
Article
๐
2007
๐
John Wiley and Sons
๐
French
โ 102 KB
## Introduction: The Glucagon-like-Peptide-1 (GLP-1) receptor is an interesting target in tumor diagnosis and therapy with Exendin-based radiopeptides as it is overexpressed on human insulinomas and gastrinomas. We have recently shown high therapeutic efficacy using a radiopeptide labeled with the